Fraser Craig

Avg. Two Year Performance

No purchase track record
86% Avg. Sale Return
37% Compound
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return(18%)0%0%0%0%
Purchase Success Rate0 of 30 of 30 of 30 of 30 of 3
Average Sale Return17%25%52%64%86%
Sale Success Rate6 of 77 of 77 of 77 of 77 of 7

Discovery Laboratories Inc.

Drugs » Biotechnology

President and CEO, Director:

Holdings: 8.64K shares

Sentiment

Insider Trading Sentiment: Accumulate

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

$4.94K Net Amount
Buy:$4.94K$0.91
Sell:0--

Aegerion Pharmaceuticals, I...

Drugs » Drug Manufacturers - Major

Chief Operating Officer:

Holdings: 0 shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--